Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Nov;33(5):425-31.
doi: 10.1165/rcmb.F307.

One hundred years of research in the pathogenesis of pulmonary hypertension

Affiliations
Review

One hundred years of research in the pathogenesis of pulmonary hypertension

Ari Zaiman et al. Am J Respir Cell Mol Biol. 2005 Nov.
No abstract available

PubMed Disclaimer

Figures

<b>Figure 1.</b>
Figure 1.
Timeline of significant achievements in the last 100 years of pulmonary hypertension research.
<b>Figure 2.</b>
Figure 2.
Pulmonary vascular remodeling in a lung of a patient with IPAH. (a) Pulmonary artery with medial hypertrophy (arrowhead), with intima thickening by longitudinally oriented smooth muscle cells (arrow). (b) Pulmonary artery with marked medial and intima thickening, with crenated internal elastic layer (dark arrow), suggestive of vasoconstriction. (c) Peripheral muscularization of a small precapillary pulmonary artery (arrowhead), also showing intima thickening. (d) Peripheral pulmonary artery with collagenous intima thickening (arrow). (e) Plexiform lesion (arrow) surrounded by markedly vascular dilation compromising both vessels draining the lesion and in alveolar capillaries (arrowheads). (f) Longitudinal section of a pulmonary artery with a concentric arrangement of elongated smooth muscle cell–like cells (arrow) and a plexiform lesion (flanked by arrowheads). (g) Concentric lesion cross-sectioned (arrow). (h) Plexiform lesion (arrowheads) and an adjoining pulmonary artery with marked intima thickening leading to reduction of vascular lumen (bar = 20 μm in a–d and g; 200 μm in e, f, and h).

References

    1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:S5–S12. - PubMed
    1. Fishman AP. A century of primary pulmonary hypertension. In: Rubin LJ, Rich S, editors. Primary pulmonary hypertension, 1st ed. New York: Marcel Decker; 1997. pp. 1–17.
    1. Arrilaga FC. Sclerose de l'artere pulmonaire a certains etats pulmonaries chroniques. Archives Maladie Coeur 1913;6:518–529.
    1. Gilmour JR, Evans W. Primary pulmonary hypertension. J Pathol Bacteriol 1946;58:687–697. - PubMed
    1. Zhu L, Wigle D, Hinek A, Kobayashi J, Ye C, Zuker M, Dodo H, Keeley FW, Rabinovitch M. The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest 1994;94:1163–1171. - PMC - PubMed